164 related articles for article (PubMed ID: 2188300)
1. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Erlemann R; Sciuk J; Bosse A; Ritter J; Kusnierz-Glaz CR; Peters PE; Wuisman P
Radiology; 1990 Jun; 175(3):791-6. PubMed ID: 2188300
[TBL] [Abstract][Full Text] [Related]
2. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Shapeero LG; Henry-Amar M; Vanel D
Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
[No Abstract] [Full Text] [Related]
3. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
4. Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging.
Liu PT; Chivers FS; Roberts CC; Schultz CJ; Beauchamp CP
Radiology; 2003 Jun; 227(3):691-700. PubMed ID: 12773675
[TBL] [Abstract][Full Text] [Related]
5. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.
Fletcher BD
AJR Am J Roentgenol; 1991 Oct; 157(4):825-33. PubMed ID: 1892044
[TBL] [Abstract][Full Text] [Related]
6. MR imaging findings in recurrent primary osseous Ewing sarcoma.
Kauffman WM; Fletcher BD; Hanna SL; Meyer WH
Magn Reson Imaging; 1994; 12(8):1147-53. PubMed ID: 7854020
[TBL] [Abstract][Full Text] [Related]
7. Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.
Lemmi MA; Fletcher BD; Marina NM; Slade W; Parham DM; Jenkins JJ; Meyer WH
AJR Am J Roentgenol; 1990 Aug; 155(2):343-6. PubMed ID: 2115265
[TBL] [Abstract][Full Text] [Related]
8. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Fletcher BD; Hanna SL; Fairclough DL; Gronemeyer SA
Radiology; 1992 Jul; 184(1):243-8. PubMed ID: 1319075
[TBL] [Abstract][Full Text] [Related]
9. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J
AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673
[TBL] [Abstract][Full Text] [Related]
10. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
[TBL] [Abstract][Full Text] [Related]
11. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Adachi N; Ochi M
Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
[TBL] [Abstract][Full Text] [Related]
12. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
[TBL] [Abstract][Full Text] [Related]
13. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
[TBL] [Abstract][Full Text] [Related]
14. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
15. [Evaluation of bone diseases using dynamic bone scintigraphy].
Kumano M; Tamura K; Hamada T; Ishida O; Kajita A; Ushio K; Okuno T
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Dec; 43(12):1393-406. PubMed ID: 6425801
[No Abstract] [Full Text] [Related]
16. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
17. Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy.
van der Woude HJ; Bloem JL; Schipper J; Hermans J; van Eck-Smit BL; van Oostayen J; Nooy MA; Taminiau AH; Holscher HC; Hogendoorn PC
Radiology; 1994 May; 191(2):421-31. PubMed ID: 8153316
[TBL] [Abstract][Full Text] [Related]
18. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Hanna SL; Parham DM; Fairclough DL; Meyer WH; Le AH; Fletcher BD
Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
[TBL] [Abstract][Full Text] [Related]
19. Primary pelvic bone tumours in children and adolescents--imaging correlation.
Hugosson C; Lindahl S; Rifai A
Acta Radiol; 1994 Nov; 35(6):549-54. PubMed ID: 7946676
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases.
Kobayashi Y; Ozaki T; Takeda Y; Kawai A; Inoue H
Acta Orthop Scand; 1998 Dec; 69(6):611-6. PubMed ID: 9930108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
